These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12880982)

  • 21. Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin.
    Lundberg BB; Griffiths G; Hansen HJ
    Int J Pharm; 2000 Sep; 205(1-2):101-8. PubMed ID: 11000546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
    Vingerhoeds MH; Steerenberg PA; Hendriks JJ; Dekker LC; Van Hoesel QG; Crommelin DJ; Storm G
    Br J Cancer; 1996 Oct; 74(7):1023-9. PubMed ID: 8855969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
    Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
    J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.
    Uyama I; Kumai K; Yasuda T; Tagawa T; Ishibiki K; Kitajima M; Tadakuma T
    Jpn J Cancer Res; 1994 Apr; 85(4):434-40. PubMed ID: 8200855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes.
    Sapra P; Allen TM
    Clin Cancer Res; 2004 Apr; 10(7):2530-7. PubMed ID: 15073133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposome drug delivery system for murine neuroblastoma.
    Nagae I; Koyanagi Y; Ito S; Tanabe Y; Unezaki S
    J Pediatr Surg; 1998 Oct; 33(10):1521-5. PubMed ID: 9802805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
    Mamot C; Drummond DC; Noble CO; Kallab V; Guo Z; Hong K; Kirpotin DB; Park JW
    Cancer Res; 2005 Dec; 65(24):11631-8. PubMed ID: 16357174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
    Brignole C; Pagnan G; Marimpietri D; Cosimo E; Allen TM; Ponzoni M; Pastorino F
    Cancer Lett; 2003 Jul; 197(1-2):231-5. PubMed ID: 12880987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.
    Nishikawa K; Asai T; Shigematsu H; Shimizu K; Kato H; Asano Y; Takashima S; Mekada E; Oku N; Minamino T
    J Control Release; 2012 Jun; 160(2):274-80. PubMed ID: 22020380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
    Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
    J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and evaluation of pH-sensitive immunoliposomes for enhanced delivery of anticancer drug to ErbB2 over-expressing breast cancer cells.
    Li T; Amari T; Semba K; Yamamoto T; Takeoka S
    Nanomedicine; 2017 Apr; 13(3):1219-1227. PubMed ID: 27965166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells.
    Gholizadeh S; Dolman EM; Wieriks R; Sparidans RW; Hennink WE; Kok RJ
    Pharm Res; 2018 Mar; 35(4):85. PubMed ID: 29516187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Stealth liposomes in a murine model of human small cell lung cancer.
    Moreira JN; Gaspar R; Allen TM
    Biochim Biophys Acta; 2001 Dec; 1515(2):167-76. PubMed ID: 11718672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.
    Brignole C; Bensa V; Fonseca NA; Del Zotto G; Bruno S; Cruz AF; Malaguti F; Carlini B; Morandi F; Calarco E; Perri P; Moura V; Emionite L; Cilli M; De Leonardis F; Tondo A; Amoroso L; Conte M; Garaventa A; Sementa AR; Corrias MV; Ponzoni M; Moreira JN; Pastorino F
    J Exp Clin Cancer Res; 2021 Jun; 40(1):180. PubMed ID: 34078433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of anti-p185HER2 immunoliposomes for cancer therapy.
    Park JW; Hong K; Carter P; Asgari H; Guo LY; Keller GA; Wirth C; Shalaby R; Kotts C; Wood WI
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1327-31. PubMed ID: 7877976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.